North America Leads Global Hormone Replacement Therapy Market due to Developed Economy

Transparency Market Research, a reputed research company, offers a thoroughly researched report about the global hormone replacement therapy market. The research report, titled “Hormone Replacement Therapy Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 – 2018,” details the important elements influencing the trajectory of the market. Furthermore, it also uses market measurement tools such as SWOT analysis and Porter’s five forces analysis to determine the strengths, weaknesses, opportunities, and threats and the threats from new entrants, the threat of substitute products or services, the bargaining power of customers, the bargaining power of suppliers, and the intensity of competitive rivalry in the market. Additionally, expert industry analysts have also studied this market from a political, economic, social, technological, legal, and environmental point of view to provide a holistic outlook of the global hormone replacement therapy market.

Browse Full Report:

Hormone replacement therapy (HRT) refers to helping patients suffering from declining levels of hormones with the right administration of hormones into the body. These therapies are generally meted out to women undergoing menopause. Estrogen is among the most commonly administered hormones. However, progesterone and testosterone are also administered when needed. These hormones are administered through implants, oral tables, vaginal creams, and patches, amongst others.

According to the research report, the global hormone replacement therapy market is segmented into estrogen replacement therapy, thyroid hormone replacement therapy, and growth hormone replacement therapy. Currently, the estrogen replacement therapy segment holds the largest share in the global hormone replacement therapy market. The largest consumers of estrogen replacement therapy are post-menopausal women. Growth hormone therapy is used for children, while thyroid replacement therapies are applied to elderly people.

The key growth driver of the global hormone replacement therapy market is the increasing awareness about post-menopausal problems amongst women. The other noteworthy growth drivers are the emergence of innovative drug delivery methods and the unmet needs in Asian markets. Geographically, North America holds the largest share in the global hormone replacement therapy market due to its developed economy and increasing purchasing power of patients.

Some of the key players profiled in the global hormone Noven Pharmaceuticals, Amgen, Pfizer, BioSante Pharmaceuticals, and Merck & co., QuatRx Pharmaceuticals, and Depomed Inc., amongst others. The research report details the competitive landscape of the global hormone replace therapy market by analyzing the key market drivers and restraints and the impact of the regulatory framework. The research report also offers an insightful take on the financial overview, research and development activities, business and marketing strategies, product portfolio, and strategic mergers and acquisitions of these top players.

Download Report Brochure:

About Us:-
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact Us:-
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

Back to home page